Resolution of synovitis and arrest of catabolic and anabolic bone changes in patients with psoriatic arthritis by IL-17A blockade with secukinumab: results from the prospective PSARTROS study

BACKGROUND: Although the effects of interleukin-17A (IL-17A) inhibition on the signs and symptoms of psoriatic arthritis (PsA) are well defined, little is known about its impact of local inflammatory and structural changes in the joints. The PSARTROS study was designed to elucidate the effects of IL...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Res Ther
Main Authors: Kampylafka, Eleni, d’Oliveira, Isabelle, Linz, Christina, Lerchen, Veronika, Stemmler, Fabian, Simon, David, Englbrecht, Matthias, Sticherling, Michael, Rech, Jürgen, Kleyer, Arnd, Schett, Georg, Hueber, Axel J.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6063019/
https://ncbi.nlm.nih.gov/pubmed/30053825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-018-1653-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados